Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Substitution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111718372B discloses a novel axial chiral ligand enabling high-yield asymmetric allylic substitution with simplified synthesis for cost-effective API manufacturing.
Novel Ni-catalyzed asymmetric method for chiral quaternary carbon alpha-amino acid esters. High yield, excellent ee, scalable process for API intermediates.
Patent CN111718372B discloses a novel axial chiral ligand enabling high-yield asymmetric allylic substitution with excellent enantioselectivity for cost-effective API manufacturing.
Patent CN111718372B enables high-purity fine chemical production through innovative ligand technology with reduced lead time and scalable manufacturing solutions for pharmaceutical intermediates.